UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000025694
Receipt number R000029558
Scientific Title Development of a bright light therapy apparatus
Date of disclosure of the study information 2017/01/24
Last modified on 2018/04/06 12:19:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Development of a bright light therapy apparatus

Acronym

Development of a bright light therapy apparatus

Scientific Title

Development of a bright light therapy apparatus

Scientific Title:Acronym

Development of a bright light therapy apparatus

Region

Japan


Condition

Condition

Sleepiness

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate safety and effects of bright light therapy with reduced blue light on sleepiness

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

calculation task score immediately after light therapy

Key secondary outcomes

subjective sleepiness on rising
subjective sleep quality
sublingual temperature
sleep quality
total sleep time


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

No light, or 10000-lux light of which the blue light content was reduced by 50% or 30%, is administered from 0500 to 0530 for four consecutive days each, with four-day intermission.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

25 years-old >=

Gender

Male

Key inclusion criteria

healthy men

Key exclusion criteria

subjects who are treated for any illnesses

Target sample size

6


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Jun Miura

Organization

Hokkaido Pharmaceutical University

Division name

Pharmacotherapy

Zip code


Address

7-15-4-1 Maeda, Teine, Sapporo, Hokkaido, Japan

TEL

011-676-8700

Email

miura-j@hokuyakudai.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Jun Miura

Organization

Hokkaido Pharmaceutical University

Division name

Pharmacotherapy

Zip code


Address

7-15-4-1 Maeda, Teine, Sapporo, Hokkaido, Japan

TEL

011-676-8700

Homepage URL


Email

miura-j@hokuyakudai.ac.jp


Sponsor or person

Institute

Muroran Institute of Technology, College of Design and Manufacturing Technology

Institute

Department

Personal name



Funding Source

Organization

Muroran Institute of Technology, College of Design and Manufacturing Technology

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

室蘭工業大学もの創造系領域
室蘭工業大学保健管理センター


Other administrative information

Date of disclosure of the study information

2017 Year 01 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 12 Month 01 Day

Date of IRB


Anticipated trial start date

2017 Year 01 Month 24 Day

Last follow-up date

2017 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete

2017 Year 08 Month 15 Day

Date analysis concluded

2017 Year 09 Month 25 Day


Other

Other related information



Management information

Registered date

2017 Year 01 Month 16 Day

Last modified on

2018 Year 04 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029558


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name